PRODUCT DETAIL

Dasatinib Teva 100 mg

Code

0637D

MA number

44/0056/19-S

Product Form:

tbl flm 30x100 mg (fľ.HDPE)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EA	BCR-ABL tyrosine kinase inhibitors
L01EA02	Dasatinib

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	05.03.2019
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Dasatinib Teva 100 mg_08.2022.pdf
PIL:	PIL_Dasatinib Teva 100 mg_08.2022.pdf
Safety feature	Yes
Data update:	04.05.2023